Research progress on probiotics for chronic kidney disease
10.3760/cma.j.cn341190-20250418-00501
- VernacularTitle:益生菌治疗慢性肾脏病的研究进展
- Author:
Jintang HU
1
;
Jiamei DI
Author Information
1. 安徽理工大学研究生院，淮南 232001
- Publication Type:Journal Article
- Keywords:
Kidney failure, chronic;
Gastrointestinal microbiome;
Enterobacteriaceae;
Uremia;
Renal dialysis;
Prebiotics;
Bifidobacterium animalis;
Inflammation
- From:
Chinese Journal of Primary Medicine and Pharmacy
2025;32(10):1597-1600
- CountryChina
- Language:Chinese
-
Abstract:
Chronic kidney disease is characterized by complex pathophysiology. In recent years, research has indicated that gut microbiota dysbiosis plays a key role in the progression of chronic kidney disease. In patients with chronic kidney disease, the intestinal barrier function is compromised, allowing enteric metabolic toxins and bacterial translocation into the systemic circulation, which exacerbates the systemic inflammatory response associated with chronic kidney disease. Probiotics, as active microorganisms that regulate gut microbiota, have gradually attracted attention for their potential role in the treatment of chronic kidney disease. This review focuses on the research progress on probiotics for the treatment of chronic kidney disease.
